首页> 外文期刊>Regulatory Mechanisms in Biosystems >Impact of corvitin and alpha-ketoglutarate on heart morphology, expression and activity of matrix metalloproteinases 2/9 in the heart of rats with doxorubicin-induced cardiomyopathy
【24h】

Impact of corvitin and alpha-ketoglutarate on heart morphology, expression and activity of matrix metalloproteinases 2/9 in the heart of rats with doxorubicin-induced cardiomyopathy

机译:Corvitin和Alpha-Ketoglutarate对大鼠心脏病患者心脏形态学,对基质金属蛋白酶酶的心态,表达和活性的影响

获取原文
获取外文期刊封面目录资料

摘要

The anthracycline anticancer drug doxorubicin is an effective and frequently used chemotherapeutic agent for various malignancies but it causes acute ventricular dysfunction, and also induces cardiomyopathy and heart failure. One of the mechanisms of cardiotoxicity of doxorubicin is oxidative stress, which stimulates myocardial remodeling. Matrix metalloproteinases MMP2 and MMP9 play a key role in this process. Despite extensive research, the expression and activity of these enzymes in the doxorubicin-damaged heart and the effect of antioxidants on these indicators have not been sufficiently studied. The aim of this work was to study the possible cardioprotective effect of the antioxidant drugs corvitin and alpha-ketoglutarate in rats with doxorubicin-induced cardiomyopathy. Cardiomyopathy in rats was induced by intraperitoneal administration of doxorubicin at the dose of 2.5 mg/kg body weight weekly for 28 days. Animals were divided into four groups: group 1 (control) received saline injections (2.5 mL/kg); group 2 – injections of doxorubicin, 3 – corvitin (5 mg/kg) 60 minutes before doxorubicin administration, 4 – doxorubicin and 1% solution of alpha-ketoglutarate in drinking water ad libitum. Heart weight and shape indexes, the ratio of muscle to connective tissues, and heart histology were examined 7 days after the end of drug administration. Activity of MMP2 and MMP9, their intracellular distribution in myocardial tissues were evaluated by gelatin-zymography and immunohistochemistry. It was found that doxorubicin cardiomyopathy in rats was accompanied by a decrease in heart weight index, adaptive change of heart shape from ellipsoid to globular, increase of connective tissue content. Administration of doxorubicin results in profound lesion of the cardiomyocytes of the atria and ventricle, manifested by excessive cytoplasmic expression of MMP2 and MMP9 and an increase their activity in the heart. Antioxidants corvitin and alpha-ketoglutarate have insufficient regenerative effect on mass and shape indexes of heart however, exhibit potent cardioprotective effect by regulation of expression and activity of MMP2 and MMP9.
机译:蒽环菌抗癌药物多柔比星是一种有效且经常使用的化学治疗剂,用于各种恶性肿瘤,但它会导致急性心室功能障碍,并诱导心肌病和心力衰竭。多柔比星的心毒性的机制之一是氧化应激,氧化应激,刺激心肌重塑。 MATIX金属蛋白酶MMP2和MMP9在该过程中发挥关键作用。尽管研究了广泛的研究,但尚未充分研究这些酶在多柔比蛋白受损的心脏中的表达和活性和抗氧化剂对这些指标的影响。这项工作的目的是研究抗氧化药物Corvitin和Alpha-Ketoglutarate在具有多柔比蛋白诱导的心肌病的大鼠中的可能的心脏保护作用。通过腹膜内施用大码霉素在每周2.5mg / kg体重28天的剂量下诱导大鼠的心肌病。将动物分为四组:第1组(对照)获得盐水注射(2.5ml / kg);第2组 - 在多柔比星给药前60分钟内注射多柔比星,3 - 蛹(5mg / kg)60分钟,4 - 多柔比星和1%的α-酮戊酸溶液在饮用水广告中。心脏重量和形状指标,药物施用结束后7天检查肌肉与结缔组织的比例和心脏组织学。通过明胶 - 酶谱和免疫组化评估MMP2和MMP9的活性,它们在心肌组织中的细胞内分布。发现大鼠的多柔比星心肌病症伴随着心脏重量的减少,心脏形状的适应性变化,从椭圆形到球状,增加结缔组织含量。对多柔比星的给药导致阿里亚和心室的心肌细胞的深刻病变,表现出MMP2和MMP9的过量细胞质表达,并在心脏中增加它们的活性。抗氧化剂Corvitin和Alpha-Ketoglutarate对心脏的质量和形状指数没有足够的再生效果,但是通过调节MMP2和MMP9的表达和活性表现出有效的心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号